Targeting CXCR4/CXCL12 axis in combination with JAK and BCL2 inhibitors showed diminished infiltration of the central nervous system by T-ALL in a xenograft model [100]. The gene discussed is CXCL12; the disease is acute lymphoblastic leukemia.